Company Description
ABPRO HLDGS (OTC Link: ABPO) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $955.7K.
ABPO stock has declined 22.9% over the past year. Shares last traded at $0.2047.
On a trailing twelve-month basis, ABPRO HLDGS reported net income of -$2.9M and diluted earnings per share of $-1.30.
This page provides a comprehensive overview of ABPO stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ABPRO HLDGS (ABPO) stock last traded at $0.2047, up 2.86% from the previous close. Over the past 12 months, the stock has lost 22.9%. At a market capitalization of $955.7K, ABPO is classified as a micro-cap stock with approximately 5.9M shares outstanding.
Latest News
SEC Filings
ABPRO HLDGS has filed 5 recent SEC filings, including 1 Form 8-K, 1 Form 10-Q, 1 Form NT 10-Q, 1 Form 10-K/A. The most recent filing was submitted on June 4, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ABPO SEC filings →
Financial Highlights
net income was -$2.9M. Diluted earnings per share stood at $-1.30. With a current ratio of 0.10, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in ABPRO HLDGS (ABPO) currently stands at 33.7 thousand shares, down 22.1% from the previous reporting period, representing 0.7% of the float. Over the past 12 months, short interest has decreased by 59.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for ABPRO HLDGS (ABPO) currently stands at 1.0 days, down 43.8% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.7 days.
ABPO Company Profile & Sector Positioning
ABPRO HLDGS (ABPO) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.